High Intensity Focused Ultrasound Market growing at a CAGR of 7.22% from 2025 to 2030

The global high intensity focused ultrasound market size was estimated at USD 1.3 billion in 2024 and is projected to reach USD 1.98 billion by 2030, growing at a CAGR of 7.22% from 2025 to 2030. Major factors contributing to the market growth include the increasing prevalence of cancer and other chronic disorders, growing prevalence of minimally invasive procedures, technological advancements, and the increasing adoption of non-oncological applications.

Key Market Trends & Insights

  • North America high intensity focused ultrasound market held the largest revenue share of 29.47% in 2024.
  • The high intensity focused ultrasound market in the U.S. held the largest market share in 2024.
  • By application, the dermatology segment dominated the market by capturing a revenue share of 20.6% in 2024.
  • By end use, the hospital segment dominated the market with a revenue share of over 40% in 2024.

Market Size & Forecast

  • 2024 Market Size: USD 1.3 Billion
  • 2030 Projected Market Size: USD 1.98 Billion
  • CAGR (2025-2030): 7.22%
  • North America: Largest market in 2024
  • Asia Pacific: Fastest growing market

Request Free Sample Report: https://www.grandviewresearch.com/industry-analysis/high-intensity-focused-ultrasound-hifu-market-report/request/rs1

For instance, according to the International Agency for Research on Cancer (IARC), in 2022, about 19,976,499 new cancer cases were reported globally.

High intensity focused ultrasound (HIFU) is an efficient technique as it uses focused ultrasound waves to generate precise and localized heat, which can effectively target and destroy diseased tissue without the need for invasive surgical procedures. This less-invasive approach minimizes damage to surrounding healthy tissues and reduces recovery time for patients. HIFU is particularly useful in treating various types of tumors, including prostate, liver, and kidney cancers. The growing prevalence of cancers worldwide is expected to have a positive impact on industry growth.

Besides cancer treatment, High Intensity Focused Ultrasound (HIFU) is also being increasingly used for non-oncological applications due to its precision and minimally invasive nature. For instance, HIFU is highly effective in treating uterine fibroids, providing a non-surgical alternative that reduces recovery time and associated risks. In neurological disorders, HIFU is employed for conditions like essential tremor and Parkinson’s disease, offering targeted brain lesioning without the need for open surgery.

In addition, HIFU is gaining popularity in the cosmetic industry for procedures such as skin tightening and body contouring. These cosmetic applications benefit from HIFU’s ability to precisely target and heat deep layers of the skin, stimulating collagen production and reducing fat cells, leading to improved skin texture and body shape without the need for invasive methods. For instance, in March 2024, Pure Tone Aesthetics announced the launch of its Pure Tone Aesthetics Inofus HIFU machines. This state-of-the-art device transforms non-invasive facial and body contouring, providing affordable treatments with reliable, proven results.

Continuous technological advancements in HIFU devices and procedures have significantly improved their efficiency, safety, and effectiveness, making them increasingly attractive to both healthcare providers and patients. Innovations such as the Mini HIFU machine, also known as a home-use HIFU device, example of such technology include ULTRAISER P1, ULTRAISER P1 Pro, Portable HIFU Device by ULTRAISER. These compact and portable devices are designed for personal use in the comfort of one’s home, offering a smaller and less powerful version of the professional HIFU machines used in clinics or medical spas. This makes advanced skincare and body contouring treatments more accessible and convenient.

Market Concentration & Characteristics

The high intensity focused ultrasound industry is accelerating at a high pace and has seen significant innovation driven by advancements in medical technology, increasing demand for less-invasive treatment options, and the integration of AI technologies. Medical technology advancements have led to the development of more precise and efficient HIFU devices, capable of targeting tissues with greater accuracy while minimizing damage to surrounding areas. This has broadened the application range of HIFU, making it suitable for treating various medical conditions, from cancers to cosmetic concerns.

Major players in the high intensity focused ultrasound industry are continuously working to improve their product offerings in order to expand their customer base and gain a larger industry share. This involves upgrading their products, exploring acquisitions, obtaining government approvals, and engaging in important cooperation activities. For instance, in November 2023, Shvabe Holding, a part of Rostec State Corporation, is conducting clinical trials of the DIATER-M HIFU system for tumor diagnostics and treatment. This represents the first Russian medical solution for tumor resection using the safer method of ultrasound. Commercial production of the equipment is scheduled to begin in 2024.

The degree of innovation in High Intensity Focused Ultrasound (HIFU) devices is remarkable, driven by continuous advancements in technology and growing demand for less-invasive treatment options. For instance, in May 2023 , Researchers from Spain and the UK developed a new focused ultrasound system designed to use hyperthermia to treat multiple tumor spheroids simultaneously. This innovation will enable potential tumor treatments to be tested more rapidly.

In addition to manufacturers, service providers in the healthcare sector are actively pursuing various initiatives to offer patients advanced treatments. This includes mergers and acquisitions aimed at expanding service capabilities, improving patient access to high-end technologies, and enhancing overall healthcare delivery. For instance, in April 2024, HIFU Prostate Services, LLC (HPS), a provider of non-invasive treatments for prostate cancer using HIFU, announced the acquisition of specific HIFU assets from Vituro Health, LLC (Vituro). Vituro brings with it a network of physicians and existing hospital contracts that will enhance and expand the HPS platform.

High Intensity Focused Ultrasound Market Report Scope

Report Attribute

Details

Market size value in 2025

USD 1.40 billion

Revenue forecast in 2030

USD 1.98 billion

Growth rate

CAGR of 7.22% from 2025 to 2030

Actual data

2018 – 2024

Forecast period

2025 – 2030

Quantitative units

Revenue in USD million/billion and CAGR from 2025 to 2030

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Application, end use, region

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Country scope

U.S.; Canada; Mexico; UK; Germany; France; Italy; Spain; Denmark; Sweden; Norway; Japan; China; India; Australia; Thailand; South Korea; Brazil; Argentina; South Africa; Saudi Arabia; UAE; Kuwait

Key companies profiled

Focal One; Sonablate Corp.; Verasonics, Inc.; Alpinion Medical Systems Co., Ltd.; Theraclion; Chongqing Haifu Medical Technology Co., Ltd.;

Lynton Lasers Ltd; ULTRAISER, Profound Medical Inc.

Customization scope

Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

 

Similar Posts